Image credit: USA Today Sports

San Francisco Giants signed LHP Tony Watson to a two-year, $9 million contract. [2/16]

In 2014 and 2015 combined, Pittsburgh’s Tony Watson pitched 152 2/3 innings in 155 games. He posted a 1.77 ERA, 2.77 FIP, and 3.08 DRA, allowing a homer to only one out of every 75 batters faced. Hitters compiled a .570 OPS against him.

Then, on July 30, 2016, the Pirates traded their closer, Mark Melanconwho would be a free agent at the end of the seasonto the Nationals for Felipe Rivero. Up to that date, Melancon had a 2.66 ERA, with a .601 OPS against and a homer every 44 batters faced. In his absence, Pittsburgh manager Clint Hurdle started calling for Watson an inning later, as the left-handed, eighth-inning setup man became the team’s closer.

Since then, Watson lost the closer job to Rivera and was traded to the Dodgers for two Single-A lottery tickets last season. He’s posted a 3.49 ERA and allowed opponents to hit  .272/.328/.445 since Melancon was traded, giving up a homer every 26 plate appearances. Frame of reference: Last year the National League hit .254/.325/.423 with a homer every 32 plate appearances. Watson’s K/BB of 2.9, while better than average, is a far cry from his 2014-2015 mark of 4.5.

Full access to this article is for Baseball Prospectus subscribers.

Sign up today to get access to insightful analysis for the discerning baseball fan.

Super-Premium - $66.99 for 1 yearPremium - $45.95 for 1 yearPremium Monthly - $4.95 / monthBasic - Free
You need to be logged in to comment. Login or Subscribe

Baseball Prospectus uses cookies on this website. They help us to understand how you use our website, which allows us to provide an improved browsing experience. Cookies are stored locally on your computer or mobile device and not by BP. To accept cookies continue browsing as normal. You will see this message only once. Privacy Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. See the BP Cookie Policy for more information. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.